|
DPM3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.476600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.748100E-02 |
| Normal-vs-Stage2 |
9.255000E-01 |
| Normal-vs-Stage3 |
3.644000E-01 |
| Normal-vs-Stage4 |
4.085200E-01 |
| Stage1-vs-Stage2 |
3.797000E-01 |
| Stage1-vs-Stage3 |
1.334400E-02 |
| Stage1-vs-Stage4 |
6.749000E-01 |
| Stage2-vs-Stage3 |
5.092200E-01 |
| Stage2-vs-Stage4 |
4.220800E-01 |
| Stage3-vs-Stage4 |
2.622400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.139800E-01 |
| Normal-vs-AfricanAmerican |
4.468800E-01 |
| Normal-vs-Asian |
2.522800E-01 |
| Caucasian-vs-AfricanAmerican |
9.030600E-01 |
| Caucasian-vs-Asian |
2.468400E-01 |
| AfricanAmerican-vs-Asian |
3.650000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.648780E-01 |
| Normal-vs-Female |
7.711800E-01 |
| Male-vs-Female |
3.838600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.698030E-01 |
| Normal-vs-Extreme_Weight |
4.829600E-02 |
| Normal-vs-Obese |
6.638200E-01 |
| Normal-vs-Extreme_Obese |
3.411200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.953400E-01 |
| Normal_Weight-vs-Obese |
9.879600E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.956800E-01 |
| Extreme_Weight-vs-Obese |
1.564320E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.113400E-01 |
| Obese-vs-Extreme_Obese |
1.990390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.495400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.336400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.565900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.231000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.620600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.611600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.455400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.480960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.289400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.792040E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.735700E-03 |
| Normal-VS-Type2 PRCC |
1.963900E-02 |
| Normal-VS-KIRP CIMP |
5.309800E-01 |
| Normal-VS-Unclassified PRCC |
8.545400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.26800031480445E-10 |
| Type1 PRCC-VS-KIRP CIMP |
4.240800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.323900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.690800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.196980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.615600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.003600E-01 |
| Normal-vs-N1 |
1.956820E-01 |
| Normal-vs-N2 |
9.954600E-01 |
| N0-vs-N1 |
7.508000E-02 |
| N0-vs-N2 |
7.605600E-01 |
| N1-vs-N2 |
5.458800E-01 |
|
|
